A Comparison between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients with Clinically Significant Macular Edema KoriAnne Elkins.

Slides:



Advertisements
Similar presentations
The Diabetic Retinopathy Clinical Research Network
Advertisements

The Diabetic Retinopathy Clinical Research Network
Evan (Jake) Waxman MD PhD
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema: Potential impact of.
Welcome to CNIB’s InFocus Webinar Series
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
containing xanthophyll (yellow) pigment.
Are Network Results Regarding Ocular Coherence Tomography (OCT) Relevant to Clinical Practice and Clinical Trials? Sponsored by the National Eye Institute,
IMAGING in AMD From Fluorescein Angiography To the Spectral Domain OCT
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection Abstract Purpose: To evaluate pseudophakic cystoid macular edema.
SAMIR AL-MANSOURI, MD. e.g. - cataract - glaucoma - macular degeneration - diabetic retinopathy Chronic = slowly progressive visual loss Major causes:
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
Optical Coherence tomography Imaging of Spontaneous closure of Psuedophakic full thickness macular hole, 8 months post operative Dr. Jenin Patel Lotus.
Vitrectomy Outcomes in Eyes with Diabetic Macular Edema, Visual Loss, and Vitreomacular Traction Sponsored by the National Eye Institute, National Institutes.
Diabetic Retinopathy. Diabetic retinopathy is the most common cause of new cases of blindness among adults years of age. Each year, between 12,000.
Interpretation of SD-OCT Gella Laxmi 2009PHXF013P.
The Diabetic Retinopathy Clinical Research Network Comparison of Visual and OCT Outcomes in Eyes with and without Prior Vitrectomy Receiving Anti- Vascular.
The Diabetic Retinopathy Clinical Research Network 5-Year Follow-up of a Randomized Trial Evaluating Ranibizumab Plus Prompt versus Deferred Laser for.
Factors Associated with Changes in Visual Acuity and OCT Thickness at 1 Year after Treatment for Diabetic Macular Edema Sponsored by the National Eye Institute,
European Association for Vision and Eye Research – Crete, Oct 5-8, 2011 Ranibizumab for the Treatment of Exudative Age-Related Macular Degeneration Associated.
The Diabetic Retinopathy Clinical Research Network
Laser-Ranibizumab-Triamcinolone for DME Study DRCR.net Protocol I
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: VEGFA and VEGFR1 and Response to Anti-VEGF Hagstrom SA, Ying G, Pauer GJT, et.
Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD,
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
The Diabetic Retinopathy Clinical Research Network Green or Yellow Laser for Diabetic Macular Edema Sponsored by the National Eye Institute, National Institutes.
Comparison of Modified ETDRS and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema Sponsored by the National Eye Institute,
A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.
The Diabetic Retinopathy Clinical Research Network What is the Role of Laser In Treating Diabetic Macular Edema in the Era of Anti-VEGF Therapy? 1.
The Diabetic Retinopathy Clinical Research Network
Prospective, Randomized, Double-Blind Study Comparing Nepafenac 0.1% (Nevanac™) and Bromfenac Sodium 0.09% (Xibrom™) in Post-Op Cataract Patients Hon-Vu.
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 1 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 2 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Sponsored by the National Eye Institute,
Phase 2 Evaluation of Intravitreal Bevacizumab for DME Sponsored by the National Eye Institute, National Institutes of Health, U.S. Department of Health.
COMPARATIVE EFFICACY OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR OEDEMA J.A. Montero, J.M. Ruiz-Moreno VISSUM, Alicante.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Single-Nucleotide Polymorphisms and Age-Related Macular Degeneration Maguire MG,
Date of download: 6/1/2016 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved. From: Optical Coherence Tomography.
BRVO. Present by Sattar Heidari MD General ophthalmologist.
Visual prognostic indicators in traumatic macular hole surgery SGN
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Normal Macular Thickness Measurements in Healthy.
The Diabetic Retinopathy Clinical Research Network Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs Deferred Laser Treatment: 3-year.
1. Ankara University School of Medicine, Department of Ophthalmology
Reproducibility of retinal thickness measurements in eyes with
Copyright © 2012 American Medical Association. All rights reserved.
Assessment of Foveal Avascular Zone in Diabetic Retinopathy by Optical Coherence Tomography Angiography and Correlation Analysis with Peripheral Perfusion.
Ultra Wide-Field Angiographic Characteristics of Branch Retinal and Hemicentral Retinal Vein Occlusion Ophthalmology 2010;117 Ap. 양지욱/R4 김성일.
Volume 113, Issue 7, Pages 1187.e e12 (July 2006)
Correlation between Optical Coherence Tomography and Fluorescein Angiography Findings in Diabetic Macular Edema  Tomohiro Otani, MD, Shoji Kishi, MD 
Analysis of Macular Edema after Cataract Surgery in Patients with Diabetes Using Optical Coherence Tomography  Stephen J. Kim, MD, Robert Equi, MD, Neil.
Role of vitrectomy the treatment of diabetic macular edema
EPIRETINAL MEMBRANES IN PATIENTS WITH UVEITIS: MORPHOLOGICAL AND FUNCTIONAL ANALYSIS WITH SPECTRL-DOMAIN OPTICAL L. Iannetti, P. Tortorella, R. Spena,
Correlation between visual acuity
Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment  Byung Gil Moon, MD, Taewoong.
The Diabetic Retinopathy Clinical Research Network
DIABETIC RETINOPATHY Süleyman ÖZEN.
The Diabetic Retinopathy Clinical Research Network
From: Error Correction and Quantitative Subanalysis of Optical Coherence Tomography Data Using Computer-Assisted Grading Invest. Ophthalmol. Vis. Sci..
당뇨황반부종에서의 레이저 치료 의정부 성모병원 안과 양지욱.
Modern retinal laser therapy
Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor.
F.Fazel,MD. F.Fazel,MD The treatment of Diabetic Retinopathy.
J. Fernando Arevalo, MD FACS Clínica Oftalmológica Centro Caracas
A new way to see abnormal blood vessels in AMD
The Diabetic Retinopathy Clinical Research Network
Intense Exercise Causing Central Retinal Vein Occlusion in a Young Patient: Case Report and Review of the Literature Case Rep Ophthalmol 2014;5:
Progression of a drusenoid RPE detachment to choroidal neovascularisation (CNV) over a 6 year period. Progression of a drusenoid RPE detachment to choroidal.
Diabetic Retinopathy Clinical Research Network
Figure 3: Female patient, 57 years old
The Diabetic Retinopathy Clinical Research Network
Presentation transcript:

A Comparison between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients with Clinically Significant Macular Edema KoriAnne Elkins Galler, M.D. Resident’s Day May 30 th, 2008

Introduction Macular edema is the most common cause of decreased visual acuity and quality of life in diabetic patients Slit lamp biomicroscopy is the gold standard for diagnosis based on the ETDRS criteria Laser photocoagulation is the mainstay of treatment for CSME

Vascular leakage can be qualitatively measured with fluorescein angiography (FA) –Provides guidance for application of focal laser –Leakage can be present without clinical evidence of edema Optical coherence tomography (OCT) is a non-invasive way to calculate macular thickening and demonstrate retinal swelling Introduction

Several authors have established a correlation between FA leakage and abnormal macular thickness or retinal swelling on OCT However, these studies have several limitations –Timing of FA and OCT data –Inclusion of only horizontal and vertical meridians for comparison Introduction Otani T, Kishi S. Correlation between Optical Coherence Tomography and Fluorescein Angiography Findings in Diabetic Macular Edema. Ophthalmology 2007;114  Kang SW, Park CY, Ham DI: The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004;137:313–322. Özdek SC, Erdinç MA, Gürelik G, Aydın B, Bahçeci U, Hasanreisog B. Optical Coherence Tomographic Assessment of Diabetic Macular Edema: Comparison with Fluorescein Angiographic and Clinical Findings. Ophthalmologica 2005;219:86–92

OCT has the potential to improve clinic efficiency In some places, OCT is being used in placed of FA In order for OCT to supplant FA, it must be able to reliably detect leakage and provide valuable information for treatment and follow-up Introduction

Purpose To evaluate the correlation between fluorescein leakage and optical coherence tomography (OCT) abnormalities in diabetic patients with clinically significant macular edema (CSME) 1. When CSME is present on clinical examination, how often do both the FA and OCT show abnormalities? 2. How often does one imaging modality miss leakage when it is present on the other? 3. How often is the OCT thickness recorded as normal when FA leakage is present?

Methods Retrospective review of 74 eyes of 48 patients with a diagnosis of CSME All patients that had fluorescein angiography (FA) and OCT testing on the same day were reviewed

Methods Treatment-naïve and treated patients (laser, intravitreal injection, or vitrectomy) were included in this study

Methods Fluorescein angiograms were graded by a single physician in a masked fashion OCTs were read independently of the FAs by a second masked physician

Methods: Fluorescein Angiography For each eye, digitized early-phase and late-phase FA images were reviewed –Early: 1-2 minutes post-injection –Late: 5-10 minutes post-injection Images were overlain with a modified ETDRS grid and type of leakage recorded

Methods: Fluorescein Angiography

Grades of FA leakage FA Leakage Types Grade 1Normal Grade 2Focal Grade 3Mixed Focal & Diffuse Grade 4Diffuse Grade 5Cystoid Macular Edema

Methods: OCT Analysis OCT was performed on a Zeiss OCT3 –6.0-mm scans in 6 meridians (every 30 degrees) for each study eye A digitized grid was created for the radial OCT scans to correspond to the same areas as the ETDRS grid

Methods: OCT Analysis

Methods: OCT Types OCT Abnormality Types Type 1Swelling without cysts Type 2Swelling with cysts Type 3A Neurosensory detachment without VMT Type 3B Neurosensory detachment with VMT

Methods: Comparison of FA’s to OCT’s

Methods: OCT Map Analysis The standard macular thickness map was used to record the thickness in 9 standard subfields Values of > 250 microns for central foveal thickness and > 300 microns for other subfields were considered abnormal

Results: Baseline Characteristics NumberPercentage Men Women Age 58 (Range 39-75) DM I613.0 DM II Treatment-naïve eyes eyes of 48 patients the study

Results: Patterns of Leakage Normal Focal Mixed Diffuse CME

2. How often does one imaging modality miss leakage when it is present on the other? 3. How often is the OCT thickness recorded as normal when FA leakage is present?

FA/OCT Correlation OCT Abnormality Negative Positive FA Leakage Positive Negative 106 (16%)47 (7.1%) 233 (35%)280 (42%) Only 42% of zone-by-zone comparisons had both an abnormal FA and OCT 74 Eyes x 9 zones per eye = 666 zones

Results: Abnormal OCT’s by FA Grade Percentage of OCT Types FA Leakage Type NormalType 1Type 2Mixed 1 (Normal) (Focal) (Mixed) (Diffuse) (Cystic) Percentage of OCT Types FA Leakage Type NormalType 1Type 2Mixed 1 (Normal) (Focal) (Mixed) (Diffuse) (Cystic)

Concordance of FA & OCT A total of 666 comparisons were made between FA and OCT zones –386 (58%) showed consistent findings –233 (35%) had an abnormal FA with a normal OCT in all 3 subscans –47 (7.1%) resulted in a normal FA with an abnormal OCT in at least one scan Cohen’s kappa of (poorly concordant)

1. When CSME is present on clinical examination, how often do both the FA and OCT show abnormalities? 2. How often does one imaging modality miss leakage when it is present on the other?

Macular Thickness Correlation & Distribution FA Leakage Pattern Abnormal OCT Thickness Measurements Inner + outer zones (67 eyes)46 eyes (64.8 %) Inner zone only (2 eyes)1 eye (50%) Outer zone only (2 eyes)0 eyes (0 %) No leakage (0 eyes)0 eyes (0 %)

Discussion Of the 280 (42%) comparisons that resulted in a mis-match between FA and OCT –233 (35%) with abnormal FA and a normal OCT –Only 47 (7.1%) instances with a normal FA but some abnormality detected on the OCT Additionally, in 35% of patients OCT thickness measurements were normal despite FA leakage

This suggests that there is a large subset of patients that will have leakage detected on FA but no comparable OCT changes or increased macular thickness Discussion

Two possibilities to account for this difference –First, these patients may still have a relatively healthy retinal pigment epithelium Able to pump out the additional fluid without leading to retinal swelling or increased thickness –Secondly, these patients may have preexisting retinal thinning that creates a falsely normal OCT

Limitations Small number of Type 1 diabetics, results may not generalize Treated vs. untreated patients not controlled for and comparison between groups was not made

In Conclusion Fluorescein is still a useful clinical tool for assessment of leakage and guiding treatment Although OCT is a less invasive testing modality for detection of DME, up to 1/3 rd of patients with active leakage will be missed OCT not surrogate for clinical exam or FA and cannot be used as a guide for placement of laser photocoagulation

Acknowledgements Rohan J. Shah, M.D. Franco Recchia, M.D.